Anti-Mouse 4-1BBL/CD137L (LALA-PG) Antibody (TKS-1)
Anti-Mouse 4-1BBL/CD137L (LALA-PG) Antibody (TKS-1) is a mouse-derived IgG2a κ antibody inhibitor that targets mouse 4-1BBL/CD137L.Anti-Mouse 4-1BBL/CD137L (LALA-PG) Antibody (TKS-1) is a chimeric version of the original TKS-1 antibody. The variable domain sequences are identical to the original TKS-1 but the constant region sequences have been switched from rat IgG2a to mouse IgG2a. Anti-Mouse 4-1BBL/CD137L (LALA-PG) Antibody (TKS-1) contains a LALA-PG mutation in the Fc fragment rendering it unable to bind to endogenous Fcγ receptors. Anti-Mouse 4-1BBL/CD137L (LALA-PG) Antibody (TKS-1) reacts with mouse 4-1BB ligand (4-1BBL). Anti-Mouse 4-1BBL/CD137L (LALA-PG) Antibody (TKS-1) can be used for the researches of cancer, infection, inflammation and immunology.
Product Specifications
CAS Number
9007-83-4
UNSPSC
12352203
Target
TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Field of Research
Cancer; Infection; Inflammation/Immunology; Others
Assay Protocol
https://www.medchemexpress.com/anti-mouse-4-1bbl-cd137l-lala-pg-antibody-tks-1.html
Solubility
10 mM in DMSO
Smiles
[Anti-Mouse4-1BBL/CD137L(LALA-PG)Antibody(TKS-1)]
Molecular Weight
(150 kDa)
References & Citations
[1]Goulet DR, Atkins WM. Considerations for the Design of Antibody-Based Therapeutics. J Pharm Sci. 2020 Jan;109(1):74-103.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD50 (ICAM-3) (186-2G9), CF740 conjugate, 0.1mg/mL
CD106 / VCAM1 (1.4C3), CF488A conjugate, 0.1mg/mL
Insulin (E2-E3), CF640R conjugate, 0.1mg/mL
